858 related articles for article (PubMed ID: 11228491)
1. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
2. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
3. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
4. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
Bombeli T; Raddatz Mueller P; Fehr J
Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
[TBL] [Abstract][Full Text] [Related]
6. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
7. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
Hofmann M; Casper F; Prellwitz W; Brockerhoff P
Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
[TBL] [Abstract][Full Text] [Related]
9. D-dimer testing in pregnancy.
Eichinger S
Semin Vasc Med; 2005 Nov; 5(4):375-8. PubMed ID: 16302159
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
11. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
[TBL] [Abstract][Full Text] [Related]
12. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
[TBL] [Abstract][Full Text] [Related]
13. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
14. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex].
von Felten A
Ther Umsch; 1992 Dec; 49(12):837-42. PubMed ID: 1485282
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
[TBL] [Abstract][Full Text] [Related]
17. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
Thromb Haemost; 1993 Dec; 70(6):909-14. PubMed ID: 8165610
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
James AH; Brancazio LR; Ortel TL
Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability after partial liver resection.
Bezeaud A; Denninger MH; Dondero F; Saada V; Venisse L; Huisse MG; Belghiti J; Guillin MC
Thromb Haemost; 2007 Dec; 98(6):1252-6. PubMed ID: 18064322
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ;
N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
